Recombinant Human LILRA5/CD85f protein (rFc Tag) (HPLC verified)
Species
Human
Purity
>90 %, SDS-PAGE
>90 %, SEC-HPLC
Tag
rFc Tag
Activity
not tested
Cat no : Eg2737
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE >90 %, SEC-HPLC |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human LILRA5 protein Gly42-Arg268 (Accession# A6NI73-1) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 353514 |
Accession | A6NI73-1 |
PredictedSize | 51.3 kDa |
SDS-PAGE | 55-65 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
LILRA5 (Leukocyte immunoglobulin-like receptor A5) belongs to a family of receptors known to regulate leukocyte activation. The transmembrane forms of LILRA5 contain a short cytoplasmic domain and a charged arginine residue within the transmembrane region that is likely to mediate its association with a yet-to-be identified ITAM-containing adaptor protein.LILRA5 is mostly expressed by monocytes and neutrophils.
References:
1. Ainslie Mitchell. et al. (2008). Eur J Immunol. 38(12):3459-3473. 2. Luis Borges. et al. (2003). Blood. 101(4):1484-1486.